08:30 AM EDT, 10/09/2024 (MT Newswires) -- UroGen Pharma ( URGN ) said Wednesday it appointed Chris Degnan as chief financial officer.
Degnan, who most recently served as CFO of Galera Therapeutics, succeeds Don Kim, who is departing to pursue other opportunities, the company said.